MA54504A - Co-cristal de kétoprofène, compositions le comprenant, son procédé de production et ses utilisations - Google Patents
Co-cristal de kétoprofène, compositions le comprenant, son procédé de production et ses utilisationsInfo
- Publication number
- MA54504A MA54504A MA054504A MA54504A MA54504A MA 54504 A MA54504 A MA 54504A MA 054504 A MA054504 A MA 054504A MA 54504 A MA54504 A MA 54504A MA 54504 A MA54504 A MA 54504A
- Authority
- MA
- Morocco
- Prior art keywords
- ketoprofen
- compositions
- crystal
- production method
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18215336.1A EP3670489A1 (fr) | 2018-12-21 | 2018-12-21 | Co-cristal de kétoprofène, compositions le comprenant, son procédé de production et ses utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA54504A true MA54504A (fr) | 2022-03-30 |
Family
ID=65013486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054504A MA54504A (fr) | 2018-12-21 | 2019-12-20 | Co-cristal de kétoprofène, compositions le comprenant, son procédé de production et ses utilisations |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12285396B2 (fr) |
| EP (2) | EP3670489A1 (fr) |
| CN (1) | CN113195445A (fr) |
| BR (1) | BR112021011368A2 (fr) |
| CA (1) | CA3122142A1 (fr) |
| IL (1) | IL283902B2 (fr) |
| MA (1) | MA54504A (fr) |
| SG (1) | SG11202105995QA (fr) |
| WO (1) | WO2020126088A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3842408A1 (fr) * | 2019-12-23 | 2021-06-30 | Dompé farmaceutici S.p.A. | Co-cristal de kétoprofène et sa préparation, compositions pharmaceutiques le contenant et ses utilisations |
| EP3900715A1 (fr) * | 2020-04-21 | 2021-10-27 | Dompe' Farmaceutici S.P.A. | Adjuvants synergiques de gabapentine et de kétoprofène, compositions pharmaceutiques et leur utilisation médicale |
| EP3907214A1 (fr) * | 2020-05-04 | 2021-11-10 | Dompe' Farmaceutici S.P.A. | Co-cristal de kétoprofène, de lysine et de gabapentine, compositions pharmaceutiques et leur utilisation médicale |
| CN119499230B (zh) * | 2024-12-24 | 2025-11-25 | 常州大学 | 酮洛芬原位共无定形组合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1497044A (en) * | 1974-03-07 | 1978-01-05 | Prodotti Antibiotici Spa | Salts of phenyl-alkanoic acids |
| IT1104556B (it) * | 1977-05-12 | 1985-10-21 | Medea Res Srl | Sale di lisina dell'acido meta-benzoil-idratropico,processo per la sua preparazione e composizione farmaceutiche che lo contengono |
| JPS59190912A (ja) | 1983-04-15 | 1984-10-29 | Hokuriku Seiyaku Co Ltd | 消炎鎮痛クリ−ム剤 |
| AU6290594A (en) * | 1993-03-09 | 1994-09-26 | Dompe Farmaceutici S.P.A. | Salts of 2-(3-benzoylphenyl)propionic acid with achiral and chiral organic bases and pharmaceutical compositions thereof |
| IT1277741B1 (it) | 1995-12-28 | 1997-11-12 | Dompe Spa | Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici |
| EP1558234B1 (fr) | 2002-10-25 | 2007-05-23 | Dompé S.P.A. | Compositions injectables indolores contenant un sel d'acides 2-arylpropioniques |
| CN1939893A (zh) | 2005-09-28 | 2007-04-04 | 北京赛生药业有限公司 | 赖氨酸酮洛芬及其制备方法 |
| RU2437657C2 (ru) | 2006-03-16 | 2011-12-27 | Новартис Аг | Твердая лекарственная форма, содержащая активный агент с маскированным вкусом |
| EP1935405A1 (fr) * | 2006-12-22 | 2008-06-25 | LEK Pharmaceuticals D.D. | Comprimés à désintégration orale |
| US9833510B2 (en) * | 2007-06-12 | 2017-12-05 | Johnson & Johnson Consumer Inc. | Modified release solid or semi-solid dosage forms |
| FR2959130A1 (fr) * | 2010-04-21 | 2011-10-28 | Sanofi Aventis | Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant. |
| ITTO20120978A1 (it) * | 2012-11-12 | 2014-05-13 | S I M S S R L Soc It Medicinali Scan | Preparazione di composti |
| CN103524365A (zh) | 2013-09-03 | 2014-01-22 | 蚌埠丰原医药科技发展有限公司 | 一种赖氨酸酮洛芬的制备方法 |
| CN104987287B (zh) | 2015-06-10 | 2017-07-18 | 上海现代制药海门有限公司 | 一种球形酮基布洛芬赖氨酸盐的制备方法 |
-
2018
- 2018-12-21 EP EP18215336.1A patent/EP3670489A1/fr not_active Withdrawn
-
2019
- 2019-12-20 MA MA054504A patent/MA54504A/fr unknown
- 2019-12-20 US US17/416,627 patent/US12285396B2/en active Active
- 2019-12-20 EP EP19820987.6A patent/EP3898569A1/fr not_active Withdrawn
- 2019-12-20 BR BR112021011368A patent/BR112021011368A2/pt unknown
- 2019-12-20 WO PCT/EP2019/025464 patent/WO2020126088A1/fr not_active Ceased
- 2019-12-20 IL IL283902A patent/IL283902B2/en unknown
- 2019-12-20 SG SG11202105995QA patent/SG11202105995QA/en unknown
- 2019-12-20 CN CN201980084329.1A patent/CN113195445A/zh active Pending
- 2019-12-20 CA CA3122142A patent/CA3122142A1/fr active Pending
-
2025
- 2025-03-14 US US19/079,567 patent/US20250312301A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN113195445A (zh) | 2021-07-30 |
| WO2020126088A1 (fr) | 2020-06-25 |
| US20250312301A1 (en) | 2025-10-09 |
| SG11202105995QA (en) | 2021-07-29 |
| EP3670489A1 (fr) | 2020-06-24 |
| EP3898569A1 (fr) | 2021-10-27 |
| IL283902A (en) | 2021-07-29 |
| IL283902B2 (en) | 2024-10-01 |
| US12285396B2 (en) | 2025-04-29 |
| US20220071936A1 (en) | 2022-03-10 |
| CA3122142A1 (fr) | 2020-06-25 |
| IL283902B1 (en) | 2024-06-01 |
| BR112021011368A2 (pt) | 2022-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3399029A4 (fr) | Virus mutant, son procédé de préparation et son application | |
| EP3367677A4 (fr) | Appareil d'étalonnage, procédé d'étalonnage et programme d'étalonnage | |
| MX377710B (es) | Anticuerpos monoclonales contra bcma. | |
| EP3340051A4 (fr) | Système de configuration de ressources, procédé de configuration de ressources et programme de configuration de ressources | |
| EP3329943A4 (fr) | Procédé de production de dispositif médical, et dispositif médical | |
| EP3560260A4 (fr) | Procédé de sélection de ressources | |
| MA54504A (fr) | Co-cristal de kétoprofène, compositions le comprenant, son procédé de production et ses utilisations | |
| PL3142785T3 (pl) | Sposób wytwarzania alkenoli i ich zastosowanie do wytwarzania 1,3- butadienu | |
| MA45797A (fr) | Mutant de mg53, son procédé de préparation et ses utilisations | |
| EP3447082A4 (fr) | Film hautement diélectrique, ses utilisations et son procédé de fabrication | |
| EP3572404A4 (fr) | Hétérocomplexe de butylphthalide-telmisartan, procédé de préparation et application associés | |
| EP3893864A4 (fr) | Co-cristaux, leurs procédé et appareil de formation | |
| EP3556769A4 (fr) | Dérivé de polyximine, procédé de préparation et application associés | |
| EP3299395A4 (fr) | Acide -1,4-oligoglucuronique oxydé, son procédé de préparation et ses utilisations | |
| EP3412679A4 (fr) | Magnésium de baïcaline, son procédé de préparation et son application | |
| EP3364403A4 (fr) | Pilote de grille, son système de configuration et son procédé de configuration | |
| FR3044415B1 (fr) | Procede de determination de la reaction d'un microorganisme a son exposition a un antibiotique | |
| EP3336095A4 (fr) | Acide beta-1,4-oligoglucuronique oxydé, son procédé de préparation et ses utilisations | |
| EP3674353A4 (fr) | Hydrogel, son utilisation, et son procédé de production | |
| EP3395834A4 (fr) | Anticorps anti-tpbg et son procédé de préparation, conjugué et son utilisation | |
| DK3923914T3 (da) | Afabicin-formulering, fremgangsmåde til fremstilling deraf | |
| EP3810526A4 (fr) | Support, ébauche et procédé de formation de support | |
| FR3037082B1 (fr) | Systeme de production de dihydrogene, et procede associe | |
| EP3354731A4 (fr) | Composition de linalool et son procédé de production | |
| FR3037805B1 (fr) | Carbonate de calcium carbonate, son procede de fabrication, ses utilisations |